Personalized rehabilitation program for patients undergoing bone marrow transplantation
APOLLO: Personalized rehAbilitation PrOgram in aLLOgeneic Bone Marrow Transplantation
This study is testing a personalized support program using an app and expert help for people recovering from bone marrow transplants to see if it can improve their physical and mental health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 45 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Alberta Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Edmonton, Alberta) |
| Trial ID | NCT05579678 on ClinicalTrials.gov |
What this trial studies
This study focuses on individuals who have undergone allogeneic bone marrow transplantation for blood cancers, which often results in severe side effects due to high doses of chemotherapy. The APOLLO team aims to understand the experiences of these patients by providing them with a supportive care app and access to nursing, exercise, and nutrition experts via telephone. Through qualitative research, the study will identify the most effective types and timing of support needed to alleviate long-term physical and psychological effects. The goal is to enhance the rehabilitation process for these patients who often face challenges in accessing care.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals eligible for allogeneic bone marrow transplantation.
Not a fit: Patients who are not undergoing allogeneic transplantation will not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and recovery outcomes for patients after bone marrow transplantation.
How similar studies have performed: While there may be similar supportive care approaches, this specific program's focus on personalized rehabilitation in the context of allogeneic transplantation is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * eligible for allogeneic transplantation Exclusion Criteria: * none
Where this trial is running
Edmonton, Alberta
- University of Alberta — Edmonton, Alberta, Canada (Recruiting)
Study contacts
- Study coordinator: Edith Pituskin, PhD
- Email: pituskin@ualberta.ca
- Phone: 7804328221
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.